Jeanne Tie on Circulating Tumor DNA, Minimal Residual Disease, and Adjuvant Treatment – The ASCO Post

AACR Annual Meeting 2021 Jeanne Tie, MD, MBChB, of the Peter MacCallum Cancer Centre, discusses how to improve the current, somewhat imprecise, approach based on pathologic staging alone, used to select patients for adjuvant treatment. Circulating tumor DNA analysis after curative-intent treatment may detect minimal residual disease and might be…

Read the full article here

Related Articles